相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey Lazarus et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
Roberto A. Calle et al.
NATURE MEDICINE (2021)
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis
Xiao-Jing Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques
Xiao-Jing Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
Leigh Goedeke et al.
HEPATOLOGY (2018)
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
GASTROENTEROLOGY (2018)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation
Chai-Wan Kim et al.
CELL METABOLISM (2017)